Delaware Chapter of the American College of CardiologyOur purpose is to contribute to the prevention of cardiovascular diseases, to ensure optimal quality of care for individuals with such diseases, and to foster the highest professional ethical standards. Please let us know what information you want to see here. Feel free to contact us with your ideas, needs and comments. |
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Latest in Cardiology from ACC.org
- Screening for AAA in Sweden vs. FinlandWhat is the difference in incidence and repair of abdominal aortic aneurysms (AAAs) between countries with different screening practices?
- Antithrombotic Therapy in Patients at High Bleeding Risk: Key PointsThe following are key points to remember from a state-of-the-art review on antithrombotic therapy in patients at high bleeding risk (HBR) from the Working Group of Thrombosis of the Italian Society of Cardiology.
- Recaticimab Monotherapy in Patients With Nonfamilial Hypercholesterolemia and Mixed HyperlipemiaThe goal of the REMAIN-1 trial was to assess the lipid-lowering efficacy and safety of recaticimab, a long-acting monoclonal antibody targeting proprotein convertase subtilisin/kexin type 9 (PCSK9).
- ANCORS-YW: Higher BMI Associated With Higher CV Risk in WomenWomen with a higher BMI may have a higher prevalence of cardiovascular risk factors, according to an analysis of the ANCORS-YW study presented during ACC Middle East 2024.
- Potassium Supplementation and the Prevention of Afib After Cardiac Surgery: TiGHT-K TrialIn this interview, Drs. Steven Nissen and Benjamin O’Brien discuss the TIGHT K trial results which proved that practitioners can safely cease the widespread practice of maintaining high-normal potassium levels after isolated coronary artery bypass grafting surgery.